Article info
PDFExperimental colitis
Targeting delivery of anti-TNFα oligonucleotide into activated colonic macrophages protects against experimental colitis
- Correspondence to Professor J Zhang, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China; jfzhang{at}nju.edu.cn
Citation
Targeting delivery of anti-TNFα oligonucleotide into activated colonic macrophages protects against experimental colitis
Publication history
- Revised July 23, 2009
- Accepted August 18, 2009
- First published December 1, 2009.
Online issue publication
October 26, 2017
Article Versions
- Previous version (26 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited For permission to use, (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.